Study of the Reliability of a Device (HumanSens Plus) Allowing Immediate Measurement Uric Acid in the Blood Obtained by Finger Tip Puncture. (URICA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02671656|
Recruitment Status : Unknown
Verified January 2016 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was: Not yet recruiting
First Posted : February 2, 2016
Last Update Posted : February 2, 2016
|Condition or disease||Intervention/treatment|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Reliability Assessment of the HumaSens Plus Measurement of Uricemia in Capillary Blood|
|Study Start Date :||March 2016|
|Estimated Primary Completion Date :||April 2016|
|Estimated Study Completion Date :||April 2016|
- Device: Uricemia
serum uric acid levels is measured once from venous blood samples in the biochemistry laboratory using standard automated colorimetric methods
- Uricemia [ Time Frame: Day0 ]
Comparison the measurement of uric acid level by the HumaSensplus system with the routine measurement of uric acid by the automated colorimetric uricase method (Abbot), and with a reference method: liquid chromatography coupled with mass spectroscopy.
This will be done once for every patient.
- Uricemia on capillary blood vs on serum [ Time Frame: Day0 ]Search for a systematic bias (the HumaSens measurement is on capillary blood whereas the other techniques are done on serum)
- Haematocrit, glucose and lipid levels, medications [ Time Frame: Day0 ]Search for confounding factors (haematocrit, glucose and lipid levels, medications) which may affect the results of the HumaSens measurement
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02671656
|Contact: Thomas BARDIN, MD, PhD||33 1 49 95 62 email@example.com|
|Service de Rhumatologie, Hôpital Lariboisière|
|Paris, France, 75010|
|Contact: Thomas BARDIN, MD, PhD 33 1 49 95 62 90 firstname.lastname@example.org|
|Principal Investigator:||Thomas BARDIN, MD, PhD||Assistance Publique - Hôpitaux de Paris|